Parallel Advisors, LLC Bio N Tech Se Transaction History
Parallel Advisors, LLC
- $4.18 Billion
- Q3 2024
A detailed history of Parallel Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Parallel Advisors, LLC holds 252 shares of BNTX stock, worth $28,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
252
Previous 172
46.51%
Holding current value
$28,370
Previous $13,000
123.08%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$935 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$508 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$491 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$213 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$203 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.3B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...